Speaker illustration

Doctor Ioannis Akoumianakis

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Interactions of circulating, digoxin-like, steroids with rate control therapy for atrial fibrillation in the RATE-AF randomised clinical trial

Event: ESC Congress 2023

Topic: Rate Control

Session: The role of rate control and comorbidities in atrial fibrillation


Wnt5a contributes to human atherosclerosis via novel USP17 redox signalling

Event: ESC Congress 2019

Topic: Coronary Microcirculation and Collaterals

Session: Coronary microcirculation


NADPH oxidase activity in internal mammary arteries predicts mortality in patients undergoing coronary bypass surgery

Event: ESC Congress 2018

Topic: Inflammation and Immunity

Session: Inflammation and immunity. A translational view


Insulin triggers oxidative stress in the vascular wall of patients with atherosclerosis, independently of systemic insulin resistance: the beneficial role of DPP-IV inhibition

Event: ESC Congress 2018

Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes

Session: Young Investigator Award Session Coronary Pathophysiology and Microcirculation


Perivascular adipose tissue-derived Wnt5a as a regulator of human vascular disease pathogenesis

Event: ESC Congress 2018

Topic: Lipids, Metabolism

Session: Best Posters in vascular disease pathogenesis


Novel insights into the role of insulin-like growth factor 1 in the regulation of myocardial redox state in humans

Event: ESC Congress 2016

Topic: Basic mechanisms

Session: Neuro-hormonal activation: target in HF


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb